Evidence map›Paper›PMID 36966292›Full record

ArticleBMC medical genomics2023

Weighted gene co-expression network analysis revealed T cell differentiation associated with the age-related phenotypes in COVID-19 patients.

Yao Lin, Yueqi Li, Hubin Chen, Jun Meng, Jingyi Li, Jiemei Chu, Ruili Zheng, Hailong Wang, Peijiang Pan, Jinming Su and 4 more

Open access · goldFull text read
In one paragraph

Article in BMC medical genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Yao Lin *Medical Laboratory Centre, Life Sciences Institute, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Yueqi Li *Department of Biochemistry and Molecular Biology, School of Basic Medicine, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Hubin Chen *Medical Laboratory Centre, Life Sciences Institute, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Jun MengMedical Laboratory Centre, Life Sciences Institute, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Jingyi LiBiosafety Level 3 Laboratory and Guangxi Collaborative Innovation Centre for Biomedicine, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Jiemei ChuMedical Laboratory Centre, Life Sciences Institute, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Ruili ZhengBiosafety Level 3 Laboratory and Guangxi Collaborative Innovation Centre for Biomedicine, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Hailong WangBiosafety Level 3 Laboratory and Guangxi Collaborative Innovation Centre for Biomedicine, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Peijiang PanBiosafety Level 3 Laboratory and Guangxi Collaborative Innovation Centre for Biomedicine, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Jinming SuBiosafety Level 3 Laboratory and Guangxi Collaborative Innovation Centre for Biomedicine, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Junjun JiangMedical Laboratory Centre, Life Sciences Institute, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Li YeBiosafety Level 3 Laboratory and Guangxi Collaborative Innovation Centre for Biomedicine, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Hao LiangMedical Laboratory Centre, Life Sciences Institute, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Sanqi AnMedical Laboratory Centre, Life Sciences Institute, Guangxi Medical University, Nanning, 530021, Guangxi, China. ansq@mail2.sysu.edu.cn.
Guangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The risk of severe condition caused by Corona Virus Disease 2019 (COVID-19) increases with age. However, the underlying mechanisms have not been clearly understood. The dataset GSE157103 was used to perform weighted gene co-expression network analysis on 100 COVID-19 patients in our analysis. Through weighted gene co-expression network analysis, we identified a key module which was significantly related with age. This age-related module could predict Intensive Care Unit status and mechanical-ventilation usage, and enriched with positive regulation of T cell receptor signaling pathway biological progress. Moreover, 10 hub genes were identified as crucial gene of the age-related module. Protein-protein interaction network and transcription factors-gene interactions were established. Lastly, independent data sets and RT-qPCR were used to validate the key module and hub genes. Our conclusion revealed that key genes were associated with the age-related phenotypes in COVID-19 patients, and it would be beneficial for clinical doctors to develop reasonable therapeutic strategies in elderly COVID-19 patients.

Indexed as

COVID-19PhysiciansCell DifferentiationGene Expression ProfilingGene Regulatory NetworksHumansPhenotypeAgingCOVID-19T-cell immunityWeighted gene

Identifiers

PMID36966292
PMCPMC10039774
OpenAlexW4360952589

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read17
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.